INTRODUCTION {#S1}
============

T follicular helper (Tfh) cells are specialized CD4^+^ T cells primarily found in germinal centers (GCs) of secondary lymphoid organs ([@R12]; [@R46]; [@R72]). Tfh cells play a critical role in supporting B cell responses and selection of affinity-matured antibodies ([@R12]; [@R13]; [@R52]). They mediate their effects via receptor-ligand interactions with B cells and production of cytokines such as interleukin-21 (IL-21), IL-4, and the B-cell activating factor (BAFF), which induce survival and proliferation in B cells and support antibody class switching ([@R4]; [@R15]; [@R49]). Expression of the chemokine receptor CXCR5 is fundamental for migration of pre-Tfh cells to the T-B cell border in lymphoid tissues and maturation of Tfh cells into B cell follicles and GCs along the follicular CXCL13 gradient ([@R2]; [@R30]). In addition to CXCR5, Tfh cells also express PD-1 and ICOS (inducible T-cell costimulator) ([@R18]; [@R26]; [@R38]; [@R86]). Some memory CD4^+^ T cells in secondary lymphoid organs express intermediate levels of these markers, but Tfh cells within the GC (Tfh GC cells) express high levels of CXCR5 and PD-1; hence, a CXCR5^hi^PD-1^hi^ phenotype is commonly used to distinguish Tfh GC cells ([@R73]). Differences in expression of these surface markers reflect the location of CD4^+^ T cell sub-populations and their activation, differentiation, and functional status ([@R21]).

Populations of CD4^+^ memory T cells in the blood with similar characteristics as lymphoid Tfh cells are thought to represent circulating memory Tfh (cTfh) cells ([@R21]; [@R34]). These peripheral cTfh cells express CXCR5, PD-1, and ICOS but at much lower levels than Tfh GC cells, although a minute population of circulating PD-1^hi^CXCR5^hi^ CD4^+^ T cells can also be detected ([@R39]; [@R83]). Although there is some controversy about phenotypic definition of cTfh cells, it is accepted that circulating CXCR5^+^CD4^+^ T cells promote immunoglobulin (Ig) class switching and plasmablast formation in co-culture with naive or memory B cells ([@R7]; [@R39]; [@R51]; [@R55]). Different subsets of cTfh cells have been distinguished: Th1-like (CXCR3^+^CCR6^−^), Th2-like (CXCR3^−^CCR6^−^), and Th17-like (CXCR3^−^CCR6^+^) cTfh cells, based on similarities with canonical Th CD4^+^ cell subpopulations ([@R7]; [@R55]). The diversity of cTfh cells is also evidenced by the differences in cytokine production and transcription factor expression observed when cTfh cell subsets are co-cultured with naive B cells in the presence of staphylococcal enterotoxin B (SEB). Th1-like subsets produce interferon γ (IFN-γ); Th2-like IL-4, IL-5, and IL-13; and Th17-like IL-17A and IL-22 ([@R7]; [@R55]).

The Th2- and Th17-like subsets of cTfh cells provide better B cell help *in vitro* than Th1-like cTfh cells ([@R9]; [@R50]; [@R55]), and the transcriptional profile of CXCR3^−^ cTfh cells shares a strong similarity with Tfh GC cells ([@R50]). In influenza virus infection, the human CD4^+^ T cell response is highly Th1-biased, and Th1-like (CXCR3^+^) cTfh cells help B cells produce virus-specific antibodies ([@R7]; [@R60]). However, stimulation of Th1-like Tfh effector cells after infection or vaccination is associated with an inferior GC response and suboptimal antibody production ([@R10]; [@R22]; [@R58]; [@R69]).

Difficulties in sampling secondary lymphoid organs in humans have hampered direct comparison of lymphoid and peripheral Tfh cell populations. Furthermore, the ontogeny of memory cTfh cells and their relationship with effector Tfh GC cells are still poorly understood. Although the phenotype ([@R17]; [@R39]) and transcriptional profile ([@R42]; [@R50]) of cTfh cell populations have been compared with Tfh GC cells, the extent of clonal convergence between these populations has not been fully explored. Phenotype and function are plastic features of CD4^+^ T cells, influenced by environmental stimuli, so the same cell type can show a different phenotypic profile in different compartments or under different cell culture conditions ([@R70]). It has been unclear whether cTfh cells originate from CXCR5^−^ memory CD4^+^ T cells or from lymphoid tissue pre-Tfh or Tfh GC cells or whether they comprise a distinct lineage. Understanding the relationship between Tfh and non-Tfh cell populations in the blood and lymphoid tissues is very important for human studies, which typically investigate only peripheral blood because of the practical, ethical, and consensual barriers to accessing lymphoid tissues.

The T cell receptor (TCR) is a fixed marker of clonotype. In this study, donor-matched tonsils and peripheral blood were collected from adult volunteers undergoing tonsillectomy, and the TCR repertoires of Tfh and non-Tfh cell subsets were determined. Considerable overlap was found between peripheral and tonsillar Tfh cells and a complete disparity between Tfh cells and CXCR5^−^ memory CD4^+^ T cells. In addition, memory Tfh and non-Tfh cells from blood reactive with the hemagglutinin (HA) protein from influenza virus were studied ([@R1]; [@R29]; [@R71]). HA-specific CD4^+^ memory T cells were enriched in CXCR3^+^ cTfh cells, and HA-specific cTfh cell clones could be found in the tonsillar CXCR3^+^ Tfh population, confirming the clonotypic overlap between peripheral and tonsillar Tfh cell populations in an antigen-specific context. Thus, human blood samples, which are readily accessible, can be used to gain insight into the specificity of Tfh cell responses occurring in GCs, but only when cTfh cell populations are analyzed.

RESULTS {#S2}
=======

Identification of Tonsillar and Circulating Tfh Populations in Donor-Matched Samples {#S3}
------------------------------------------------------------------------------------

Matched peripheral blood and tonsil samples from adult donors were studied to compare cTfh and tonsillar Tfh (tTfh) cell populations. Multi-parameter flow cytometry-based characterization of CD4^+^ memory T cell populations in peripheral blood mononuclear cells (PBMCs) and mononuclear cells from tonsils (MNC-Ts) was performed ([Figure 1](#F1){ref-type="fig"}). We refer to all antigen-experienced (CD4^+^CD45RA^−^) cells as memory cells, although this definition encompasses central memory and effector memory/effector T cells, which we did not distinguish in this study. Expression of the Tfh markers CXCR5, PD-1, and ICOS and the chemokine receptor CXCR3 on CD4^+^CD45RA^−^ memory T cells (identified as shown in [Figure S1A](#SD1){ref-type="supplementary-material"}) was evaluated ([Figure 1A](#F1){ref-type="fig"}). A population with high expression of PD-1 and CXCR5 was observed only in tonsils and was not present in appreciable numbers in peripheral blood samples. CXCR3 and ICOS were also differently expressed among blood and tonsil CD4^+^ memory T cells ([Figure 1B](#F1){ref-type="fig"}). In tonsils, populations with lower expression of CXCR5 and PD-1 had the highest proportion of CXCR3^+^ cells, whereas in blood, no significant difference was observed between CXCR5^+/−^ and PD-1^+/−^ subsets. In contrast, ICOS was maximally expressed in tonsil and blood populations with high expression of CXCR5 and PD-1, and it decreased as these two markers declined.

Subsets of CD4^+^ memory T cells were chosen for comparison based on the phenotypic observations made here and in prior studies ([@R9]; [@R55]; [Figure 1C](#F1){ref-type="fig"}). Within the CD4^+^CD45RA^−^ population, cTfh CXCR3^+^ and cTfh CXCR3^−^ subsets of CXCR5^+^PD-1^+^ cells and cNon-Tfh cells (CXCR5^−^) were identified in peripheral blood. In tonsils, tTfh GC cells were identified as PD-1^hi^CXCR5^hi^, in contrast to the intermediate level PD-1^int^CXCR5^int^ population, in which tTfh CXCR3^+^ and tTfh CXCR3^−^ cells were characterized, and tNon-Tfh (CXCR5^−^PD-1^−^) cells were also studied. Gates were set based on the expression of PD-1, CXCR5, and CXCR3 in CD4^+^CD45RA^+^ naive-enriched T cells ([Figure S1B](#SD1){ref-type="supplementary-material"}). Because PD-1 is often expressed by exhausted peripheral T cells and in Th17 CD4^+^ cells ([@R3]; [@R24]), we did not include this marker to gate on cNon-Tfh cells from blood to ensure that we were examining the entire non-Tfh memory population. The percentage of each population within CD4^+^CD45RA^−^ T cells was evaluated in samples collected from 12 donors ([Figure 1D](#F1){ref-type="fig"}). The Tfh GC subset was not found in appreciable numbers in peripheral blood, and Tfh subsets were less frequent in peripheral blood than in tonsils, whereas non-Tfh cells were more abundant.

To define the functionality of phenotypically distinct Tfh cell subsets, cytokine production from each subset was evaluated *ex vivo* after phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation, by flow cytometry. Data from 10 donors showed that Tfh GC cells were the major producers of IL-21 ([Figure 1E](#F1){ref-type="fig"}) and IL-4 ([Figure 1F](#F1){ref-type="fig"}), both crucial cytokines for Tfh cell differentiation and B cell survival ([@R56]; [@R67]; [@R89]). Production of IL-21 was lower in the other Tfh cell subsets and minimal in non-Tfh cells ([Figure 1E](#F1){ref-type="fig"}). No significant differences in IL-4 production were observed between Tfh CXCR3^+^, Tfh CXCR3^−^, and non-Tfh cells from both tonsils and blood ([Figure 1F](#F1){ref-type="fig"}). In line with the low expression of CXCR3 in Tfh GC cells, this population also exhibited minimal production of IFN-γ ([Figure 1G](#F1){ref-type="fig"}), consistent with published data ([@R52]; [@R63]). In contrast, the major producers of IFN-γ were Tfh CXCR3^+^ subsets from both tissues along with peripheral non-Tfh cells, which include canonical Th1 phenotype cells known to be the highest producers of anti-viral cytokines within CD4^+^ cell subsets ([@R25]; [@R55]). Examples of cytokine staining for each cell subset are illustrated in [Figures S1C](#SD1){ref-type="supplementary-material"}--[S1F](#SD1){ref-type="supplementary-material"}.

Clonotypic Overlap between Peripheral and Tonsillar Tfh Cell Populations {#S4}
------------------------------------------------------------------------

To gain insight into the relationship between cTfh and tTfh populations, a TCR repertoire analysis was performed. The TCR clonotype sequence identifies clonal populations of T cells in different tissues. To compare the TCR repertoire of CD4^+^ memory T cell populations, thawed PBMCs and MNC-Ts from 4 matched donors were stained, and tTfh GC, tTfh CXCR3^+^, tTfh CXCR3^−^, and tNon-Tfh cells from tonsils and cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh cells from blood were separated by fluorescence-activated cell sorting (FACS) (8,000--123,000 cells per subset). RNA was extracted, and 5′ (RACE) unique molecular identifiers (UMI)-controlled sequencing of the CDR3 region of the TCR Vβ chain repertoire was performed. Because fewer TCRs were sequenced from lower-frequency cell subsets, the frequency of each clonotype within its parent population was normalized, and subsequent analysis was performed on the most frequent 2,000 clonotypes (top2000) in each sample. This approach enabled insight to be gained into repertoire sharing between the most abundant clones in each of the analyzed populations.

The network analysis in [Figure 2](#F2){ref-type="fig"} illustrates the clonotypes shared between each population of blood CD4^+^ T cells (cTfh CXCR3^−^ \[[Figure 2A](#F2){ref-type="fig"}\], cTfh CXCR3^+^ \[[Figure 2C](#F2){ref-type="fig"}\], and cNon-Tfh \[[Figure 2E](#F2){ref-type="fig"}\]) and the different populations of tonsil (tTfh GC, tTfh CXCR3^+^, tTfh CXCR3^−^, and tNon-Tfh) cells without showing the connections between the tonsillar populations. The cTfh CXCR3^−^ population showed the greatest clonotype sharing with tTfh GC; a total of 6.45% of clonotypes were found to be shared between these populations overall. This contrasts with findings from a recent study where no clonal overlap was observed between tTfh GC and the blood cTfh populations studied here ([@R44]), but it is consistent with another recent report indicating that thoracic duct T cells with a CXCR5^high^ and PD-1^high^ phenotype show TCR sharing with cTfh ([@R80]). A total of 3.25% of clonotypes were uniquely shared between cTfh CXCR3^−^ and tTfh GC, whereas others were also co-shared with the tTfh CXCR3^−^ subset, with which cTfh CXCR3^−^ also showed clonotype sharing; 2.05% of clonotypes were shared between all 3 of these populations, whereas a further 2.15% of clonotypes were uniquely shared between the cTfh CXCR3^−^ and tTfh CXCR3^−^ subsets ([Figure 2A](#F2){ref-type="fig"}). In contrast, cTfh CXCR3^+^ and cNon-Tfh populations each showed extensive repertoire overlap only with the tonsil CD4^+^ population to which they were phenotypically most closely related; 12.8% of clonotypes were uniquely shared between the cTfh CXCR3^+^ and tTfh CXCR3^+^ populations ([Figure 2C](#F2){ref-type="fig"}), whereas cNon-Tfh cells uniquely shared 19.2% with tNon-Tfh cells ([Figure 2E](#F2){ref-type="fig"}). The data shown in [Figures 2A](#F2){ref-type="fig"}, [2C](#F2){ref-type="fig"}, and [2E](#F2){ref-type="fig"} are from donor 1, who underwent tonsillectomy for sleep apnea, ruling out T cell clonal distortions driven by repeated tonsil infections. However, the results obtained with the other donors were similar, and analysis of the percentage of clonotypes shared between populations in each of the 4 donors (shown in [Figures 2B](#F2){ref-type="fig"}, [2D](#F2){ref-type="fig"}, and [2F](#F2){ref-type="fig"}) confirms the overlap between cTfh CXCR3^−^ and both tTfh GC and tTfh CXCR3^−^ populations ([Figure 2B](#F2){ref-type="fig"}) and the extensive clonotype sharing of cTfh CXCR3^+^ with tTfh CXCR3^+^ cells ([Figure 2D](#F2){ref-type="fig"}) and of cNon-Tfh with tNon-Tfh cells ([Figure 2F](#F2){ref-type="fig"}). The heatmap ([Figure 2G](#F2){ref-type="fig"}) displays the number of clonotypes shared between populations for all 4 donors.

For a deeper TCR repertoire comparison, it was important to also consider the size of each clonotype (weighted analysis) to gauge the repertoire overlap in terms of cell numbers. For each tonsil and blood comparison, the normalized F2 metric of VDJtools ([@R74]) was calculated. The F2 is the sum of the geometric means between the frequencies of shared clonotypes, the greater the F2 value between two subsets, the higher the number of T cells bearing the shared TCR variants ([@R45]). This analysis confirmed the repertoire similarity of cTfh CXCR3^−^ with tTfh GC and tTfh CXCR3^−^ populations and identified a connection between cTfh CXCR3^−^ and tTfh CXCR3^+^ cells ([Figure 3A](#F3){ref-type="fig"}). Likewise, the F2 metric also validated the overlap of cTfh CXCR3^+^ with tTfh CXCR3^+^ cells ([Figure 3B](#F3){ref-type="fig"}) and the extensive overlap of cNon-Tfh with tNon-Tfh cells and identified weaker connections with tTfh populations ([Figure 3C](#F3){ref-type="fig"}).

To better visualize the similarity between these two compartments, where clonotype sharing was observed, the frequencies of each shared clonotype were analyzed by linear regression. Although there was consistent overlap between cTfh CXCR3^−^ and tTfh GC cells ([Figure 3D](#F3){ref-type="fig"}), comparison of the relative sizes of clonotypes shared by the two different compartments was significant in only 2 of the 4 donors, with a low Pearson correlation coefficient (R^2^; 0.08 and 0.14). In all cases, the slope of the correlation was less than 1, indicating that, in tonsils, most of the clonotypes are more expanded than in the blood. A similar scenario was observed for cTfh CXCR3^−^ versus tTfh CXCR3^−^ subsets ([Figure 3E](#F3){ref-type="fig"}) and cTfh CXCR3^−^ versus tTfh CXCR3^+^ populations ([Figure 3F](#F3){ref-type="fig"}). The correspondence between cTfh CXCR3^+^ and tTfh CXCR3^+^ populations remained the strongest; the sizes of the clonotypes shared between these populations were also very similar, significant (p \< 0.0001) in 3 of the 4 donors ([Figure 3G](#F3){ref-type="fig"}). For the cNon-Tfh and tNon-Tfh comparison, despite the high number of clonotypes shared (124--386), the size of the clonotypes was very different between blood and tonsils, making the linear correlation significant in only 1 of the 4 donors ([Figure 3H](#F3){ref-type="fig"}).

Repertoire Diversity Correlates with the Degree of Clonotypic Overlap from the *In Silico* Resampling Analysis {#S5}
--------------------------------------------------------------------------------------------------------------

To compare the repertoire diversity of each population, the non-parametric Chao1 index ([Figure 4A](#F4){ref-type="fig"}) was calculated to estimate the richness of the number of unobserved elements in the set considered ([@R19]; [@R28]). The normalized Shannon-Wiener index was also calculated to measure the entropy of each TCR sequence population ([Figure 4B](#F4){ref-type="fig"}) based on the uncertainty of predicting the next sequence in a string. The two parameters describe the repertoire diversity from different perspectives; Chao1 is based on relative distributions of low-frequency clonotypes, whereas Shannon-Wiener takes into account large clonal expansions ([@R45]). Notably, an increase of diversity was observed in blood from cTfh CXCR3^+^ to cTfh CXCR3^−^ and cNon-Tfh cells; likewise, in tonsils, tTfh GC cells were less diverse than tNon-Tfh subsets, which showed the highest value of both Chao1 and normalized Shannon-Wiener index values.

To improve our understanding of the magnitude of the overlap observed between CD4^+^ T cell subsets in blood and tonsils, which was based on analysis of a limited number of cells from each population, an *in silico* replication using the bootstrap method was applied to re-sample the clonotypes in each subset. When re-sampling the same subset twice, populations from the blood ([Figures 4C](#F4){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}) showed, on average, an overlap between sampling 1 and sampling 2 of 50%, with cTfh CXCR3^+^ cells slightly higher (60%--70%). In tonsil populations ([Figures 4D](#F4){ref-type="fig"} and [S2A](#SD1){ref-type="supplementary-material"}), the highest reproducibility was reported for tTfh GC cells, with decreasing levels of overlap observed for tTfh CXCR3^+^ and tTfh CXCR3^−^ populations and the lowest with tNon-Tfh cells. A similar trend was reported from the weighted analysis represented by the F2 metric analysis.

When increasing the number of clonotypes considered, the prediction did not reach complete overlap but, rather, a plateau of 60% of unweighted ([Figure 4E](#F4){ref-type="fig"}) and 0.8 weighted ([Figure 4F](#F4){ref-type="fig"}) analysis, respectively. As expected, the degree of overlap was inversely related to population diversity ([Figure 4G](#F4){ref-type="fig"}) and was more pronounced for tonsils compared with blood, confirming that, when a population is less diverse, the degree of overlap on *in silico* resampling is higher. The overlap of the same population was also assessed experimentally in non-Tfh ([Figure S2B](#SD1){ref-type="supplementary-material"}) and Tfh cells ([Figure S2C](#SD1){ref-type="supplementary-material"}) from 3 additional donors and was found to be less than 30% for non-Tfh and less than 52% for Tfh subsets.

These results show that, even when re-sampling exactly the same set of sequences or sequencing two vials of the same sorted population, the repertoire overlap is never complete (100% and F2 = 1), and it changes depending on the diversity of the subset considered and the size of the sample ([@R74]). This implies that the degree of overlap observed experimentally is an underestimate, reflecting the relatively small sample size and reinforcing the conclusion that there is substantial repertoire overlap between blood and tonsil Tfh populations.

Tfh Cell Subsets Are Clonotypically Distinct from Non-Tfh Cells {#S6}
---------------------------------------------------------------

Whether Tfh cells make up a distinct population of CD4^+^ T cells with a unique program of differentiation or are a subset of the memory CD4^+^ T cell compartment in a transient activation state is still debated ([@R5]; [@R20]; [@R43]; [@R82]; [@R84]).

A cytoscape networking analysis revealed only a very low level of TCR Vβ repertoire overlap between cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh populations in the blood compartment ([Figure 5A](#F5){ref-type="fig"}). This was true for both comparisons of cTfh CXCR3^+^ versus cTfh CXCR3^−^ (0.8%) and cTfh subsets versus cNon-Tfh (0.3%--1%) populations. In addition, very few clonotypes were shared between all 3 populations (0.2%). These results were consistent across all 4 donors analyzed ([Figure S3](#SD1){ref-type="supplementary-material"}). Similarly, tTfh cells (either CXCR3^+^, CXCR3^−^, or GC) were also notably distinct from the tNon-Tfh population ([Figure 5B](#F5){ref-type="fig"}), with very little repertoire overlap (0.1%--0.3%). In contrast, the 3 tTfh populations showed considerable overlap with each other: tTfh CXCR3^+^ with tTfh CXCR3^−^ and Tfh GC (0.8%--3.1%), tTfh CXCR3^+^ with tTfh GC (3.6%--7.4%), tTfh CXCR3^−^ with tTfh GC (4%--14.9%), and tTfh CXCR3^+^ with tTfh CXCR3^−^ (2.7%--6.3%) ([Figure 5C](#F5){ref-type="fig"}). Although the extent of the repertoire overlap between the tTfh populations was variable in different donors, clonotype sharing between the 3 tTfh cell populations was observed in all 4 donors, especially between the tTfh CXCR3^−^ and tTfh GC subsets. A normalized F2 metric analysis confirmed the overlap between tTfh CXCR3^−^ and tTfh GC subsets and the repertoire distance between all tTfh populations and tNon-Tfh ([Figure 5D](#F5){ref-type="fig"}). Despite the numerous clonotypes shared between tTfh CXCR3+ and tTfh CXCR3^−^ (70--172), tTfh CXCR3^+^ and tTfh GC (89--214), and tTfh CXCR3^−^ and tTfh GC (96--360), the relative immunodominance of the shared clonotypes differed substantially; the correlations were R^2^ \< 0.36 and, in the majority of cases, not significant ([Figure 5E](#F5){ref-type="fig"}).

Influenza Virus HA-Specific Clones Are Predominantly Found in cTfh CXCR3^+^ and cNon-Tfh Populations {#S7}
----------------------------------------------------------------------------------------------------

To compare the repertoire of antigen-specific Tfh and non-Tfh cells in peripheral blood and their representation in tonsil populations, responses to the HA protein H3 from influenza virus A/Wisconsin/67/2005 were studied ([@R1]; [@R29]; [@R71]). To assess the relative abundance of memory CD4^+^ T cells reactive with HA protein, the T cell library method ([@R31]) was used to determine the precursor frequency of HA-reactive cells in isolated memory CD4^+^ T cell populations and to characterize the cTfh and cNon-Tfh CD4^+^ memory repertoire in 3 healthy donors, samples from whom were obtained from the National Health Service (NHS) Blood Transfusion Service ([Figure 6A](#F6){ref-type="fig"}). All 3 donors showed enrichment of HA-specific T cells in the cTfh CXCR3^+^ and cNon-Tfh populations. Few responding HA-specific cTfh CXCR3^−^ cells were found, and they were only detected in donor A. The precursor frequency of antigen-specific cells per million was calculated within each subset ([Figure 6B](#F6){ref-type="fig"}). Donors A and B showed the highest HA-specific precursor frequency in both cTfh CXCR3^+^ and cNon-Tfh populations (530--550 and 280--150 antigen-specific cells/million). The differences observed in the 3 donors analyzed likely reflects the diverse prior antigenic exposure of each individual.

Having shown that HA-specific cTfh cells were present in peripheral blood, the antigen-specific cTfh repertoires of 4 further donors, from whom tonsil samples were available in addition to peripheral blood samples (donors 1,2,3, and 4), were compared with the entire repertoire of T cells in tonsillar cell subsets from the same individual. To confirm influenza virus exposure, plasma samples from the 4 donors were screened for the presence of HA-specific antibodies, evaluating immunoglobulin G (IgG) reactivity with HA protein from influenza virus strain A/California/07/2009, H1N1 ([Figure S4A](#SD1){ref-type="supplementary-material"}) and IgG reactivity with trivalent (H1, H3, and B) influenza vaccine 2017 (TIV) ([Figure S4B](#SD1){ref-type="supplementary-material"}) by ELISA. IgG antibodies reactive with both HA protein and TIV were detected in all 4 donors. Tfh cell clones specific for HA protein (H1) were then generated from peripheral blood cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh populations of each donor. As shown in [Figure 6C](#F6){ref-type="fig"}, the highest numbers of HA-specific clones were derived from either cTfh CXCR3^+^ or cNon-Tfh populations. These were the subsets in which antigen-specific cloning efficiency was greatest ([Figure S4D](#SD1){ref-type="supplementary-material"}). Based on the percentage of activated ICOS^+^CD25^+^ cells after 7 days of stimulation ([Figure S4C](#SD1){ref-type="supplementary-material"}) and the proportion of the clones generated from the activated populations that were subsequently confirmed to be HA-reactive by proliferation, it was possible to gain estimates of the number of HA-specific cells within each subset ([Figure S4E](#SD1){ref-type="supplementary-material"}) or within the CD4^+^ memory compartment ([Figure S4F](#SD1){ref-type="supplementary-material"}). The data confirmed that HA-specific T cells were enriched in the cTfh CXCR3^+^ and cNon-Tfh populations, whereas, as expected, only a few HA-specific cells were found in the cTfh CXCR3^−^ compartment ([@R7]; [@R60]).

The epitopes recognized by HA-specific T cell clones were then mapped using a matrix of overlapping peptides from HA/California (H1). The data from cTfh CXCR3^+^ and cNon-Tfh clones highlighted the breadth of HA epitopes recognized in each donor and suggested a difference in the pattern of epitopes recognized by cTfh and cNon-Tfh subsets because only a few peptides per donor were recognized by all three types of cells ([Figure 6D](#F6){ref-type="fig"}, solid arrows). Epitopes recognized by at least 3 donors are highlighted in [Figure 6D](#F6){ref-type="fig"} with dashed arrows; peptide 433--450 was the most universally targeted, being recognized by cTfh CXCR3^+^ clones from donors 2, 3, and 4 and by cNon-Tfh clones from donors 1,2, and 3. The number of cTfh CXCR3^−^ clones was low, and none of the clones recognized epitopes targeted in at least 3 donors, including peptides 433--450 and 441--458.

HA-Specific cTfh CXCR3^+^ T Cell Clonotypes Can Be Detected in the tTfh CXCR3^+^ Subset {#S8}
---------------------------------------------------------------------------------------

To determine whether clones with the same peptide specificity also express the same TCR, the CDR3α and CDR3β gene transcripts of a subset of HA-specific clones from donors 1, 2, and 3 were sequenced ([Figure 7A](#F7){ref-type="fig"}). These data showed that, when cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh cell clones were specific for the same peptide (for example, peptide 225--242 for donors 1 and 2 and peptide 177--194 for donor 3), they did not share the same CDR3 region and were therefore clonotypically distinct. In some cases, even when 2 clones were specific for the same peptide and belonged to two different lineages, they used TCRα or TCRβ chains from the same family. For instance, in donor 2, clones 49 (cTfh CXCR3^+^), 1 (cTfh CXCR3^−^), and 42 (cNon-Tfh) specific for peptide 225--242 exhibited different CDR3a sequences, but all three TCRα chains belonged to the same TRAV23/DV6 family. Also, in donor 3, clones 1 (cTfh CXCR3^+^) and 1 (cTfh- CXCR3^−^) specific for peptide 177--194, which again had different CDR3α sequences, possessed TCRβ chains belonging to the same family (TRBV2). Additional sequences from donor 1 are shown in [Figure S5A](#SD1){ref-type="supplementary-material"}.

We next investigated whether the TCRα or TCRβ chain sequences identified in HA-specific T cell clones were detectable in the overall repertoire of CD4^+^ T cell subsets from both tonsils and peripheral blood, which had been evaluated by non-paired sequencing of αβ TCRs. Because both the TCRα and TCRβ chain of each HA-specific T cell clone were available, it was possible to determine the presence or absence of each clonotype on the basis of detection of both chains in the subsets analyzed. Although only 75 HA-specific clones were sequenced, 3 cTfh CXCR3^+^ clones from donor 2 were found in the tTfh CXCR3^+^ repertoire from the same donor ([Figure 7B](#F7){ref-type="fig"}), and two clones, also from donor 2, were detected in the cTfh CXCR3^+^ subset ([Figure 7C](#F7){ref-type="fig"}). The tables show the frequency of the clonotype of interest observed in tonsils ([Figure S5B](#SD1){ref-type="supplementary-material"}) and in blood ([Figure S5C](#SD1){ref-type="supplementary-material"}) for both TCR chains. The presence of HA-specific Tfh clones initially derived from PBMCs in the tTfh CXCR3^+^ repertoire of the same donor confirmed the direct relationship between antigen-specific circulating and tTfh cells.

DISCUSSION {#S9}
==========

This work analyses the clonotypic overlap of Tfh cell subsets from peripheral blood and tonsillar cell populations. Repertoire sharing was selectively detected between blood and tonsillar populations with similar phenotypic characteristics, defined as cTfh CXCR3^+^ and tTfh CXCR3^+^, cTfh CXCR3^−^ and tTfh GC/tTfh CXCR3^−^, and cNon-Tfh and tNon-Tfh subsets. These results suggest that, in a steady-state condition, the clonal composition of the CXCR5^+^PD-1^+^ circulating cTfh population reflects that of tonsil-resident tTfh cells. The TCR repertoire analysis also provided evidence of a clear distinction between Tfh and non-Tfh cell populations. These observations were confirmed by a parallel analysis of antigen-specific T cell clones recognizing HA from influenza virus. Therefore, separation of Tfh cells from the total memory CD4^+^ T cell pool is necessary to investigate the specificity of the follicular T cell response.

In line with previous observations, Tfh GC cells (CXCR5^hi^PD-1^hi^) were the major sources of IL-21 and IL-4 and were only present in tonsils ([@R23]; [@R39]; [@R42]; [@R50]). The presence of effector Tfh GC cells in tonsils suggested a probable ongoing immune response in this tissue ([@R5]; [@R35]; [@R37]), which was likely driven by residual antigen from prior infections because antigen can persist for months or years on follicular dendritic cells in draining lymph nodes ([@R77]; [@R78]), We showed that Tfh GC cells are enriched in CXCR3^−^ cells and produced little IFN-γ ([@R52]; [@R63]). The lack of CXCR3 expression by Tfh GC cells is consistent with their specific effector function inside the GC, where they do not need to directly face inflammation but actively participate in formation of neutralizing antibodies ([@R25]; [@R39]). Phenotypic features highlighted similarities, in particular between tTfh CXCR3^+^ and cTfh CXCR3^+^ subsets, but also heterogeneity between blood and tonsil populations ([@R17]; [@R39]). These differences may be driven by stimuli present in the respective local environments ([@R85]) and reflect selective recruitment, retention, or differentiation of populations at particular sites ([@R27]).

To better determine the relationship between circulating and tTfh cell populations, we explored TCR repertoires, given that a cell's TCR does not change with cellular location or differentiation. The vast TCR diversity within each individual (estimated at 10^8^) and the number of cells sequenced per sample (10^3^--10^5^) always constrains TCR repertoire studies and poses caveats requiring the use of technical or *in silico* replicates to confirm the primary observations. However, TCR deep sequencing highlighted correlations between tonsil and blood Tfh and non-Tfh populations. Although RNA-based TCR sequencing provides relatively good repertoire coverage, it is not possible to calculate the absolute frequency of each clonotype with the analyzed populations ([@R40]; [@R68]). However, we combined both weighted (the F2 metric) and unweighted (percentage of shared clonotypes) analyses and observed similar trends, validating the repertoire overlap observed between populations.

Effector Tfh GC cells from tonsils and tTfh CXCR3^−^ cells showed a moderate repertoire overlap with cTfh CXCR3^−^ cells from peripheral blood. Although a Tfh GC/cTfh CXCR3^−^ relationship between tonsils and blood has been demonstrated previously in terms of gene expression ([@R50]), our analysis of donor-matched tissues directly demonstrates that the same Tfh clones are present in both tonsils and the blood CXCR5^+^PD-1^+^ cTfh compartment. The relatively modest overlap might be explained by the specific and localized role of Tfh GC cells during their effector phase in the GC ([@R33]). Consistent with this, we observed that shared clonotypes are more expanded in tonsils than in blood, suggesting selective retention of a locally expanded Tfh population. The clonotype sharing between tTfh GC and tTfh CXCR3^−^ cells may reflect the fact that both are enriched for cells recognizing locally presented antigens, with Tfh GC potentially originating from or sharing common precursors with Tfh CXCR3^−^ ([@R21]; [@R50]). In contrast, the cTfh CXCR3^−^ population probably has a much more promiscuous origin because it is likely to contain antigen-experienced Tfh cells that have exited from lymphoid tissues before or after becoming effector Tfh GC cells during both the ongoing and prior immune responses. It is also possible that cTfh cells are recruited from the periphery in response to local chronic infection in the tonsils.

This study does not address the differentiation and generation of Tfh CXCR3^+^ cells, but the convergence in clonotypic repertoire observed between peripheral blood and tonsils was striking. This suggests high mobility of these types of cells from secondary lymphoid organs to the peripheral circulation or vice versa. The minor but consistent repertoire sharing between Tfh CXCR3^+^ and Tfh CXCR3^−^ cells in tonsils may result from tTfh cell differentiation from one phenotype to the other or plasticity among CXCR3^+^ and CXCR3^−^ phenotypes, observed previously in canonical T helper subsets ([@R6]; [@R41]).

The repertoire sharing observed between non-Tfh cells in tonsils and blood confirms communication between the two tissues and suggests that, after priming, CD4^+^ T cells from secondary lymphoid organs may exit into the peripheral circulation to pursue their effector function but also that circulating non-Tfh cells may be recruited to the tonsils to react to ongoing chronic infection. Despite the consistent overlap, the weighted analysis showed that the size of clonotypes differed between the two compartments, indicating that these populations have a different clonotypic distribution, which probably reflects differing retention and expansion in different locations.

To better understand the magnitude of the observed repertoire overlaps, it is necessary to consider the size of the analyzed samples (10^3^--10^5^ cells) in comparison with the entire CD4^+^ T cell repertoire (10^8^ cells) in the human body, with the caveat of considering a fixed number of the most abundant clones in each subset. Importantly, it was observed that, when re-sampling exactly the same set of sequences *in silico* or by experimentally sequencing cells independently sorted from the same tissue sample, the repertoire overlap is never complete, and it decreases with increasing population diversity. These quantitative results suggest that the degree of overlap observed experimentally between separately sampled populations provides an underestimate of the considerable repertoire overlap between circulating and tTfh populations.

Extending the analysis to antigen-specific populations, we showed, using the T cell library technique ([@R31]), that HA-specific CD4^+^ T cells were enriched in the cTfh CXCR3^+^ subset and the cNon-Tfh population, which contains the canonical CD4^+^ Th1 subsets. The number of HA-specific clones generated from the cTfh CXCR3^+^ and cNon-Tfh compartments was also much higher than that generated from the cTfh CXCR3^−^ pool. The CD4^+^CXCR3^+^ bias in the HA-specific response is in line with previous reports ([@R59]; [@R61]; [@R79]; [@R81]; [@R87]; [@R88]; [@R90]). Notably, in one of the 3 donors studied, the TCR sequences of blood-derived HA-specific cTfh CXCR3^+^ clones were found in the tTfh CXCR3^+^ repertoire, supporting a common clonal origin of antigen-specific Tfh cells in tonsils and the circulation. These results from analysis of antigen-specific cells provide strong support for the conclusions drawn from TCR deep sequencing: that the repertoires of cTfh and tTfh cells are very similar to each other but distinct from non-Tfh populations. Our observation of some repertoire sharing between Tfh GC and tTfh CXCR3^+^ populations is consistent with the hypothesis that some of the cells participating in a GC reaction originate from the tTfh CXCR3^+^ pool ([@R21]; [@R39]). Whether a few Tfh GC cells, originally primed in a Th1 environment, are surviving to become memory Tfh Th1-like (or CXCR3^+^) cells in the lymphoid organs and later in the periphery is not clear ([@R21]). Tfh GC cells may revert, via a tTfh CXCR3^−^ stage, to a tTfh CXCR3^+^ phenotype because we observed some modest repertoire overlap between all three of these tTfh populations as well as repertoire overlap unique to the tTfh CXCR3^−^ and tTfh CXCR3^+^ populations. These observations may apply to other Tfh cells with different phenotypes, similar to canonical Th cell subsets, but future work focusing on different pathogens that drive Th2 orTh17 responses is needed to elucidate this further.

Our TCR repertoire analysis also indicated very little overlap between antigen-experienced Tfh and non-Tfh cell populations in blood and tonsil tissues under steady-state conditions. This may suggest that these memory cells are derived from distinct clonal lineages, although it does not exclude the possibility that memory CD4^+^ T cells, which are known to exhibit plasticity ([@R6]; [@R16]; [@R41]; [@R57]), may alter their phenotype and become Tfh cells during an acute immune response ([@R11]; [@R62]). However, given that only the top2000 most abundant clonotypes in each population were compared, we cannot preclude that clones that were more highly expanded in the Tfh compartment were not also present at low frequency in the non-Tfh compartment and vice versa. Nonetheless, there were substantial differences in the TCR repertoires of antigen-experienced Tfh and non-Tfh populations. Furthermore, when studying influenza virus-specific cells (in the absence of a current influenza infection), we found that the peptides recognized by HA-specific CD4^+^ T cell clones showed a wide diversity of specificities, and there was a surprisingly small overlap in the peptides recognized by Tfh and non-Tfh subsets. The distinction between Tfh and non-Tfh subsets in peripheral blood was uniquely confirmed by the combination of TCR sequencing and peptide specificity testing for cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh HA-reactive T cell clones; the results indicated that these cells were generated from different naive clones. Future studies should explore the differences between repertoires of Tfh and non-Tfh cells in blood and GC over the course of acute responses to infection or vaccination.

Non-Tfh cells constitute the majority of the CD4^+^ T cell population in the blood (PD-1^+^CXCR5^+^ cTfh cells comprise only 15% of memory and 6% of total blood CD4^+^ T cells), and, for many years, measurement of total CD4^+^ T cell responses in PBMCs has been used to assess the magnitude of helper T cell responses in the context of B cell and antibody responses. Our findings show that evaluation of the overall antigen-specific CD4^+^ T cell response will not give an accurate picture of the response in the Tfh compartment. There was very little clonal overlap between *bona fide* helper Tfh cells, particularly Tfh GC cells, and CXCR5^−^CD4^+^ memory T cells in the blood or tonsils, and there were marked differences in the epitope specificity of HA-reactive cTfh and cNon-Tfh cells. However, there were significant overlaps between the CXCR5^+^ Tfh populations in the blood and Tfh cells in lymphoid tissues. Therefore, to investigate the specificity of true Tfh responses, it will be necessary to identify circulating Tfh cells and to study their antigen reactivity. These findings have important implications for evaluating the breadth and specificity of immune responses in clinical trials of vaccines aimed at stimulating protective antibody responses.

STAR★METHODS {#S10}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S11}
---------------------------------------

This study did not generate new unique reagents. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrew J. McMichael (<andrew.mcmichael@ndm.ox.ac.uk>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

### Human studies {#S13}

Volunteer adult donors (16--50 years old) admitted for elective tonsillectomy at the John Radcliffe Hospital in Oxford because of a history of recurrent tonsillitis or sleep apnea consented to donate peripheral blood (80--100 mL) on the day of the surgery ([Table S6](#SD1){ref-type="supplementary-material"}). Tonsillectomy was performed in the absence of acute infection. Patients were excluded from the study if they were affected by immunodeficiency, serious ongoing infection (e.g., hepatitis B, hepatitis C or HIV infection or other infections deemed by the investigators to impact on the study), lymphoid malignancy, cytogenetic disorders, history of cancer, any pre-existing heart disease ora blood clotting disorder. The existing LABFLU002 clinical protocol was amended to cover these studies and was ethically approved by the Oxford B Research Ethics Committee (13/SC/0152). Written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki. Peripheral blood samples for T cell library interrogations were collected from healthy donors via the UK National Blood Service.

METHOD DETAILS {#S14}
--------------

### Human sample processing {#S15}

Tonsil nodules from adult donors were collected within 4 h of surgery into RPMI 1640 glutamine \[-\] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (5%, UK National Blood Service), β-mercaptoethanol (0.1%, Invitrogen) and penicillin/streptomycin (1%, Invitrogen). All samples were kept on ice during transportation. Tonsillar tissues were cleared from fatty and necrotic areas and cut into sections at a thickness of 2--3 mm using scalpels and scissors. The sections were then passed through a 70 μm cell strainer and filtered through a 40 μm cell strainer ([@R32]). Manually processed tonsils and peripheral blood samples were diluted 1:2 with Hank's Balanced Salt Solution (Sigma-Aldrich) and layered over 20 mL of Histopaque-1077 (Sigma-Aldrich). Mononuclear cells were isolated via density gradient centrifugation (800 g for 30 min). Flow cytometric analyses of phenotypic markers were performed directly *ex vivo*. CD14^+^ cells were enriched from PBMCs via magnetic separation using CD14 MicroBeads (Miltenyi Biotec).

### Phenotypic analysis and intracellular cytokine staining {#S16}

Mononuclear cells from tonsil and blood samples were washed in Dulbecco's PBS (Sigma-Aldrich). For phenotypic analyses, cells were labeled with Live/Dead Fixable Aqua and surface stained with anti-CD4--APC-Cy7, anti-CD45RA--PE-TxRed, anti-CXCR3--PE-Cy5, anti-CXCR5--AF488, anti-ICOS--BV711, anti-PD-1--BV421 and the dump markers anti-CD8, anti-CD14, anti-CD16, anti-CD19, anti-CD25 and anti-CD56 (all conjugated to PE-Cy7) for 15 min at 37°C (reagent details in [Key Resources Table](#T1){ref-type="table"}). For cytokine production, cells were stimulated with phorbol 12-myristate 13-acetate (2 × 10^−7^ M, Sigma-Aldrich) and ionomycin (1 μg/mL, Sigma-Aldrich) for 5 hr at 37°C. Brefeldin A was added after 2 hr (10 μg/mL, Sigma-Aldrich). Cells were then surface stained as described above, fixed/permeabilized with Cytofix/Cytoperm 1X Solution (BD PharMingen), and stained in Permwash 1X Solution (BD PharMingen) with anti-CD4--APC-Cy7, anti-IFN-γ--AF700, anti-IL-4--PE and anti-IL-21--AF647 for 20 min on ice (reagent details in [Key Resources Table](#T1){ref-type="table"}). The flow cytometry panel was internally validated using individually stained CompBeads (BD Biosciences). Stained samples were acquired using an LSR Fortessa (BD Biosciences) and analyzed using FlowJo software v10.3 (Tree Star).

### CD4^+^ T cell library {#S17}

CD4^+^ and CD14^+^ cells were enriched from the PBMCs of 3 healthy donors via magnetic separation using the corresponding MicroBeads (Miltenyi Biotec). The CD14^+^ fraction was cryopreserved in liquid nitrogen. CD4^+^ T cells were stained with Live/Dead Fixable Aqua, anti-CD3--BV605, anti-CD4--APC-Cy7, anti-CD45RA--PE-TxRed, anti-CXCR3--PE-Cy5, anti-CXCR5--AF488, anti-PD-1--BV421 and the dump markers anti-CD8, anti-CD14, anti-CD16, anti-CD19, anti-CD25 and anti-CD56 (all conjugated to PE-Cy7) for 15 min at 37°C (reagent details in [Key Resources Table](#T1){ref-type="table"}). Circulating live CD3^+^CD4^+^CD45RA^−^ cells were sorted into cTfh CXCR3^+^ (CXCR3^+^CXCR5^+^PD-1^+^), cTfh CXCR3^−^ (CXCR3^−^CXCR5^+^PD-1^+^) and cNon-Tfh (CXCR5^−^) subsets using a FACSAria III (BD Biosciences). Sorting was performed using a 4-way purity to obtain 3--5x10^5^ cells per subset at a minimum purity of 92%. Sorted CD4^+^ T cells were seeded at a limiting dilution of 1 × 10^4^ cells/mL in RPMI 1640 glutamine \[-\] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (5%, UK National Blood Service), β-mercaptoethanol (0.1%, Invitrogen), penicillin/streptomycin (1%, Invitrogen) and IL-2 (500 U/mL, University of Oxford). Cells were expanded with 1 μg/mL phytohemagglutinin (Remel) in the presence of irradiated (45 Gy) allogeneic feeder cells from 3 different healthy blood donors (10^6^ feeder cells/mL). After 20 days, each line was screened for the capacity to proliferate in response to HA protein. Autologous CD14^+^ monocytes were irradiated at 45 Gy and incubated (3 × 10^5^ cells/mL) for 5 hr at 37°C with HA protein (5 μg/mL) from Influenza A Wisconsin/67/2005 (a gift from Professor Stephen Harrison, Harvard Medical School). Negative control wells incorporated dimethyl sulfoxide (0.045%, Sigma-Aldrich), and positive control wells incorporated IL-2 (500 U/mL, University of Oxford). An aliquot of 2.5 × 10^6^ cells/mL from each expanded CD4^+^T cell line was added to the monocytes after washing and resting in fresh culture medium without IL-2 for 5 hr. After 3 days, 1 μCi/mL \[^3^H\]-thymidine was added to the cultures, and proliferation was measured after 16 hr using a MicroBeta2 Counter (Perkin Elmer) ([@R14]; [@R31]; [@R48]; [@R53]).

### Antigen-specific CD4^+^ T cell clones {#S18}

Frozen CD14-depleted PBMCs were defrosted and rested overnight at 37°C in RPMI 1640 glutamine \[-\] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (10%, UK National Blood Service), β-mercaptoethanol (0.1%, Invitrogen) and penicillin/streptomycin (1%, Invitrogen). CD4^+^ cells were enriched via magnetic separation using CD4 MicroBeads (Miltenyi Biotec) and surface stained as described above. Among live lymphocytes, circulating CD3^+^CD4^+^CD45RA^−^ cells were sorted into cTfh CXCR3^+^ (CXCR3^+^CXCR5^+^PD-1^+^), cTfh CXCR3^−^ (CXCR3^−^CXCR5^+^PD-1^+^) and cNon-Tfh (CXCR5^−^) subsets using a FACS Aria III (BD Biosciences). Sorted subsets (3x10^6^ cells/mL) were stimulated at a 3:1 ratio with irradiated (45 Gy) autologous CD14^+^ monocytes loaded as described above with overlapping HA peptides (2 μg/mL) corresponding to Influenza A California/04/2009 (GenScript). Peptides were 14--18 amino acids long with a 12 residue overlap spanning the entire length of HA. After 7 days, cells were stained with Live/Dead Fixable Aqua, anti-CD3--BV605, anti-CD4--APC-Cy7, anti-CD25--PE-Cy7, anti-CD45RA--PE-TxRed, anti-ICOS--PE and the dump marker anti-CD14 (conjugated to FITC) for 15 min at 37°C (reagent details in [Key Resources Table](#T1){ref-type="table"}). Activated CD4^+^ T cells (CD3^+^CD4^+^CD14^−^CD25^+^ICOS^+^) were sorted using a FACSAria III (BD Biosciences) and seeded at 0.4 cells/well into 384-well plates (Corning). Cells were expanded with phytohemagglutinin (1 μg/mL, Remel) in the presence of irradiated (45 Gy) allogeneic feeder cells from 3 different healthy blood donors (10^6^ feeder cells/mL) in RPMI 1640 glutamine \[-\] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (10%, UK National Blood Service), β-mercaptoethanol (0.1%, Invitrogen), penicillin/streptomycin (1%, Invitrogen) and IL-2 (500 U/mL, University of Oxford). After 14 days, T cell clones were identified and transferred into 96-well round-bottom plates (Corning). To confirm specificity, an aliquot of each clone (1 × 10^6^ cells/mL) was stimulated with the relevant overlapping peptide pool (2 μg/mL) after washing and resting in fresh culture medium without IL-2 for 5 hr. After 3 days, 1 μCi/mL \[^3^H\]-thymidine was added to the cultures, and proliferation was measured after 16 hr using a MicroBeta2 Counter (Perkin Elmer). Positive responses were defined as \>1,000 counts per min (cpm) with a stimulation index \>5 after background subtraction (cpm in wells lacking peptide). Clones were excluded from the analysis if the background count was \>1,000 cpm.

### Peptide-mapping of antigen-specific CD4^+^ T cell clones {#S19}

Antigen-specific CD4^+^ T cell clones were mapped using a matrix of overlapping HA peptides corresponding to Influenza A California/04/2009, designed using "Deconvolute This!" ([@R64]). The matrix consisted of 12 pools with 18 peptides per pool and a coverage of 3. An aliquot of each clone (1.5 × 10^6^ cells/mL) was added to the peptide matrix (2 μg/mL) after washing and resting in fresh culture medium without IL-2 for 5 hr. After 3 days, 1 μCi/mL \[^3^H\]-thymidine was added to the cultures, and proliferation was measured after 16 hr using a MicroBeta2 Counter (Perkin Elmer). Positive responses were defined as \>1,000 cpm with a stimulation index \>5 after background subtraction (cpm in wells lacking peptide). Peptide specificity was confirmed similarly using single peptides identified from the matrix responses.

### TCR deep-sequencing {#S20}

Mononuclear cells from matched tonsil and peripheral blood samples were defrosted and rested overnight at 37°C in RPMI 1640 glutamine \[-\] medium (Invitrogen) supplemented with non-essential amino acids (1%, Invitrogen), sodium pyruvate (1%, Invitrogen), glutamine (1%, Invitrogen), pooled AB human sera (10%, UK National Blood Service), β-mercaptoethanol (0.1%, Invitrogen) and penicillin/streptomycin (1%, Invitrogen). Cells were then surface stained as described above. Among live CD3^+^CD4^+^CD45RA^−^ lymphocytes, circulating cells were sorted into cTfh CXCR3^+^ (CXCR3^+^CXCR5^+^PD-1^+^), cTfh CXCR3^−^ (CXCR3^−^CXCR5^+^PD-1^+^) and cNon-Tfh (CXCR5^−^) subsets, and cells from tonsils were sorted into tTfh GC (CXCR5^hi^PD-1^hi^), tTfh CXCR3^+^ (CXCR3^+^CXCR5^int^PD-1^int^), tTfh CXCR3^−^ (CXCR3^−^CXCR5^int^PD-1^int^) and tNon-Tfh (CXCR5^−^PD-1^−^) subsets. A maximum of 1.2x10^5^ cells per subset was sorted using a FACSAria III (BD Biosciences) into RLT buffer (QIAGEN) containing β-mercaptoethanol (10%, Sigma-Aldrich). Sorted cells were stored at −80°C. Each subset from donors 5, 6 and 7 was sorted into two vials for technical replicates ([Table S7](#SD1){ref-type="supplementary-material"}). Total RNA was isolated using an RNeasy Mini Kit (QIAGEN). Unique molecular identifier (UMI)-labeled 5′-RACE TCRβ cDNA libraries were prepared using a Human TCR Profiling Kit (MiLaboratory LLC). All extracted RNA was used for cDNA synthesis, and all synthesized cDNA was used for PCR amplification. Libraries were prepared in parallel using the same number of PCR cycles and sequenced in parallel using a 150+150 bp NextSeq (Illumina). The total number of reads per subset is shown in [Table S8](#SD1){ref-type="supplementary-material"}.

### TCR sequencing of antigen-specific CD4^+^ T cell clones {#S21}

Antigen-specific CD4^+^ T cell clones were stained as described above for viability and surface expression of CD3 and CD4 (reagent details in [Key Resources Table](#T1){ref-type="table"}). A maximum of 5 × 10^3^ live CD3^+^CD4^+^ T cells was sorted into 100 μL of RNAlater (Ambion) using a FACSAria III (BD Biosciences). Sorted cells were stored at −80°C. All expressed *TRA* and *TRB* gene transcripts were amplified using an unbiased template-switch anchored RT-PCR ([@R66]). Pure mRNA was isolated from sorted cells using μMACS Oligo(dT) MicroBeads (Miltenyi Biotec), and cDNA was generated using a SmarterRACE Kit (Takara) with Superscript II (Invitrogen). Transcripts were amplified using an Advantage 2 PCR Kit (Takara) with the relevant constant region primers (reagent details in [Key Resources Table](#T1){ref-type="table"}). Amplicons were separated on agarose gels and extracted using a NucleoSpin Extract II Gel Extraction Kit (Macherey-Nagel). Subclones were generated using a TOPO TA Cloning Kit (Invitrogen) and One Shot Max Efficiency DH5α-T1 Competent Cells (Invitrogen). Conventional sequencing was performed as described previously ([@R65]). Gene use was assigned using the ImMunoGeneTics (IMGT) nomenclature ([@R47]).

### Quantification of influenza-specific IgG {#S22}

ELISA plates were coated with a commercial Trivalent Influenza Vaccine (0.75 μg/mL, Sanofi Pasteur) or HA protein from Influenza A/California/2009 (2 μg/mL, BEI Research Resources Repository). After overnight incubation at 4°C, plates were washed six times with PBS containing 0.05% Tween-20, blocked with casein (Pierce) for 2 hr at room temperature, and washed again with PBS containing 0.05% Tween-20. Diluted plasma samples (1:500, 1:1,000, 1:2,000 and 1:4,000) were then added in duplicate. After incubation for 2 hr at room temperature, plates were washed again six times with PBS containing 0.05% Tween-20, incubated with alkaline phosphatase-conjugated goat anti-human IgG (1 μg/mL, Sigma-Aldrich) for 1 hr at room temperature, and washed again with PBS containing 0.05% Tween-20. Para-nitrophenylphosphate (Sigma-Aldrich) dissolved at a concentration of 1 mg/mL in diethanolamine buffer (Pierce) was then added for 10 min, and absorbance was read at 405 nm using a Microplate Reader (BioTek) with Open Gen5 software (BioTek). Results were plotted as arbitrary units and standardized against a pool of four plasma samples ([@R54]).

QUANTIFICATION AND STATISTICAL ANALYSIS {#S23}
---------------------------------------

### Flow cytometry data {#S24}

A stop gate was set during acquisition to ensure that the same number of events was acquired and for each sample. Gates were set on the data to determine the frequencies of the different subsets. Analogous subsets were compared between tonsil and peripheral blood using the Wilcoxon matched pairs test. Non-analogous subsets were compared within tonsil and peripheral blood using the Kruskal-Wallis test. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001. Boxes show means and quartiles, and whiskers show minima and maxima.

### TCR deep-sequencing analysis {#S25}

A total of 93 × 10^6^TCRβ sequencing reads (up to 8 × 10^6^ reads per library) were obtained, from which 1.55 × 10^6^ unique UMI-labeled TCRβ cDNA molecules (up to 1.5 × 10^5^ molecules per library) were assembled using MIGEC software ([@R75]), using a threshold of at least four sequencing reads per UMI. In-frame CDR3β repertoires were extracted using MiXCR software ([@R8]). Each library contained from 500 to 3.5 × 10^4^ functional (in-frame, no stop-codons) CDR3b nucleotide clonotypes. Averaged TCR repertoire characteristics weighted by clonotype size (normalized Shannon-Wiener index) were calculated using VDJtools software ([@R76]). As the number of cells in the populations sorted from different donors was variable as well as the total reads, the frequency of each clonotype was normalized before analysis to allow an unbiased comparison between diverse subsets. Network analysis was performed using Cytoscape software (<https://cytoscape.org>). The F2 metric for overlap between two populations was calculated as the sum of the geometric means between the frequencies of shared clonotypes, considering the top2000 clonotypes for each subset. This value was then standardized with the two maximum F2 metrics calculated for the top2000 clonotypes for each of the two populations. F2 metric, % shared clonotypes and diversity indices were analyzed with non-parametric Kruskal-Wallis and Dunn's multiple comparison tests. For each test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001. Linear regression correlations were calculated using the square of the Pearson correlation coefficient (R^2^), the slope and the p value of the significance of the difference in the slope from zero (ns = not significant).

### Bootstrap method {#S26}

The complete set of clonotypes was randomly resampled with replacement to obtain two *in silico* replicates of each set of sequences. Using this method, the replicates and the original set had similar distributions, but likely different absolute numbers, for each clonotype. All downstream analyses were performed using the two resampled sets. Linear regression correlations between *in silico* replicates and diversity were calculated using the p value of the difference in the slope from zero.

### T cell library analysis {#S27}

Positive responses were defined as \>3,000 counts per min (cpm) with a stimulation index \>5 after background subtraction (cpm in the negative control wells). Because CD4^+^ T cells were seeded at limiting dilution, it was possible to calculate the precursor frequency of responding cells per million according to the Poisson distribution ([@R14]; [@R31]; [@R48]; [@R53]). The 95% confidence intervals were determined according to the modified Wald method ([@R36]).

### Antigen-specific CD4^+^ T cell frequencies {#S28}

The frequencies of expanded antigen-specific CD4^+^ T cell clones were calculated based on the number of clones with confirmed specificity after expansion. Significantly diverse enrichments were identified using Kruskal-Wallis and Dunn's multiple comparison tests were performed. For each test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.

DATA AND CODE AVAILABILITY {#S29}
--------------------------

MIGEC, MiXCR and VDJtools software are available from MiLaboratory LLC (<https://milaboratory.com/software/>). The TCR sequencing dataset supporting the current study has been deposited in the Mendeley Dataset repository (<https://doi.org/10.17632/wry2ddh8zx.1>).
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![Identification of Tonsillar and Circulating Tfh Populations in Donor-Matched Samples\
Matched PBMC and MNC-T from adult donors were stained *ex vivo*.\
(A) Dot plot illustrating the expression of CXCR5, PD-1, CXCR3, and ICOS within the total CD4^+^CD45RA^−^ cells in a representative matched blood and tonsil sample pair.\
(B) Heatmaps showing the mean percentage of CXCR3^+^ and ICOS^+^ cells within populations expressing different combinations of CXCR5 and PD-1 in 12 donors. The white crossed boxes indicate the near-absence of the PD-1^hi^CXCR5^hi^ population in peripheral blood.\
(C) Dot plot illustrating the gating strategy used to define populations of circulating CXCR5^+^PD-1^+^Tfh (cTfh CXCR3^+^, cTfh CXCR3^−^) and CXCR5^−^ non-Tfh memory cells (cNon-Tfh) and tonsillar CXCR5^hi^PD-1^hi^ GC Tfh (tTfh GC), CXCR5^int^PD-1^int^ (tTfh CXCR3^+^, tTfh CXCR3^−^) Tfh and CXCR5^−^PD-1^−^ non-Tfh memory cells (tNon-Tfh) within the total CD4^+^CD45RA^−^ T cell pool in one representative donor.\
(D) The percentage of each Tfh/non-Tfh subset within the CD4^+^CD45RA^−^ memory T cell population in blood and tonsils from the 12 donors.\
(E--G) Production of IL-21 (E), IL-4 (F), and IFN-γ (G) after PMA and ionomycin stimulation by Tfh and non-Tfh populations in 10 donors. Non-analogous subsets were compared within tonsil and peripheral blood using the Kruskal-Wallis test. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001. Boxes show means and quartiles, and whiskers show minima and maxima.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1548560-f0001){#F1}

![Clonotypic Overlap between Peripheral and Tonsillar Tfh Cell Populations\
The top2000 TCR CDR3β nucleotide sequences in each population were analyzed using Cytoscape networking.\
(A, C, and E) As an example, illustrated is clonotype sharing between peripheral blood cTfh CXCR3^−^ (A), cTfh CXCR3^+^ (C), and cNon-Tfh (E) and 4 tonsillar populations: tTfh CXCR3^+^ in yellow, tTfh CXCR3^−^ in blue, tTfh GC in red, and tNon-Tfh in gray in one representative donor (donor 1). Each square represents a different clonotype; the size of the square is proportional to the clonotype's normalized frequency within the parent population (for shared clonotypes, the highest normalized frequency is shown). The number of clonotypes shared between different populations is shown in bold, and the respective percentage is indicated below.\
(B, D, and F) To compare the overlap between blood cTfh CXCR3^−^ (B), cTfh CXCR3^+^ (D), and cNon-Tfh (F) subsets and tonsillar populations, the percentage of the top2000 most frequent clonotypes shared between populations was calculated in each of the 4 donors (mean ± SEM). Non-parametric Kruskal-Wallis and Dunn's multiple comparison tests: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.\
(G) A heatmap depicting the average number of clonotypes shared.](nihms-1548560-f0002){#F2}

![Size Similarities in Clonotypes Shared between cTfh and tTfh\
(A--C) Overlap between TCR CDR3β nucleotide sequences of the top2000 most frequent clonotypes of blood cTfh CXCR3^−^ (A), cTfh CXCR3^+^ (B), and cNon-Tfh (C) populations with each tonsil population, as represented by the normalized F2 metric (mean ± SEM). Non-parametric Kruskal-Wallis and Dunn's multiple comparison test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.\
(D--H) Linear regression analysis of the correlation between the within-population frequency of the shared clonotypes in the two parent populations where clonotype sharing between populations was observed: cTfh CXCR3^−^ with tTfh GC (D), tTfh CXCR3^−^ with cTfh CXCR3^−^ (E), cTfh CXCR3^−^ with tTfh CXCR3^+^ (F), cTfh CXCR3^+^ with tTfh CXCR3^+^ (G), and cNon-Tfh with tNon-Tfh (H). Each graph illustrates a representative donor, and the tables show the number of shared clonotypes, the square of the Pearson correlation coefficient (R^2^), the slope value for each donor, and the p value of the significance of the difference in the slope from zero (ns, not significant).](nihms-1548560-f0003){#F3}

![Repertoire Diversity Correlates with the Degree of Clonotypic Overlap from the *In Silico* Resampling Analysis\
(A and B) Chao1 index (A) and normalized Shannon-Wiener index (B) of the top2000 frequencies for each population of cells analyzed in blood and tonsils from the 4 donors (mean ± SEM). Clonotypes of each subset were resampled using the bootstrap method.\
(C and D) The percentage of the top2000 shared clonotypes and the normalized F2 metric (mean ± SEM) of the overlap between the two replicates of blood (C) cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh as well as tonsil (D) tTfh GC, tTfh CXCR3^+^, tTfh CXCR3^−^, and tNon-Tfh populations is shown for all 4 donors (mean ± SEM). Non-parametric Kruskal-Wallis and Dunn's multiple comparison test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.\
(E and F) Unweighted (E) and weighted (F) analysis of the replicate overlap at increasing numbers of clonotypes considered from a representative population (cTfh CXCR3^+^ from donor 1).\
(G) The graphs show the linear regression correlation between the repertoire overlap, expressed either as percentage of shared clonotypes or normalized F2 metric, with both diversity indexes (Chao1 and normalized Shannon-Wiener) in all blood and tonsil populations from the 4 donors analyzed.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1548560-f0004){#F4}

![Tfh Cell Subsets Are Clonotypically Distinct from Non-Tfh Cells\
The top2000 TCR Vβ CDR3 nucleotide sequences of each population were analyzed by Cytoscape networking.\
(A and B) Examples of (A) clonotype sharing between peripheral blood cTfh CXCR3^+^ (yellow), cTfh CXCR3^−^ (blue), and cNon-Tfh (gray) populations and (B) clonotype sharing between tonsillar populations tTfh CXCR3^+^ (yellow), tTfh CXCR3^−^ (blue), tTfh GC (red), and tNon-Tfh (gray) populations in one representative donor (donor 1). Results are expressed as in [Figure 2](#F2){ref-type="fig"}.\
(C) The percentage of the top2000 total shared clonotypes in addition to the uniquely shared clonotypes between tonsil populations was calculated in each of the 4 donors (mean ± SEM).\
(D) The normalized F2 metric of the top2000 frequencies was also calculated for the overlap between tTfh CXCR3^+^ and tTfh CXCR3^−^ subsets and each of the other populations analyzed in the 4 donors (mean ± SEM). Non-parametric Kruskal-Wallis and Dunn's multiple comparison test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.\
(E) The table shows the number of shared clonotypes, the square of R^2^ in their size within populations, the slope value, and the p value of the difference in the slope from zero.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1548560-f0005){#F5}

![Influenza Virus HA-Specific Clones Are Predominantly Found in cTfh CXCR3^+^ and cNon-Tfh Populations\
(A) T cell libraries generated from Tfh and non-Tfh subsets sorted from three healthy blood donors from the National Health Service (NHS) Blood Transfusion Service were tested against the influenza H3/Wisconsin HA protein. The proliferation of each individual cell line (increase in counts above background, delta cpm) is shown (mean ± SEM). The red dotted line represents the cutoff used for identification of a positive response (defined as \>3000 cpm, with a stimulation index \>5).\
(B) Calculated precursor frequency of HA-specific cells per 10^6^ cells in each subset (mean ± SEM).\
(C) Bar graph showing the number of influenza H1/California HA-specific T cell clones generated from each cell subset in the 4 further donors from whommatched tonsil samples were available. Non-parametric Kruskal-Wallis and Dunn's multiple comparison test: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, \*\*\*\*p \< 0.0001.\
(D) Epitopes recognized by HA-specific cTfh CXCR3^+^, cTfh CXCR3^−^, and cNon-Tfh clones were mapped, and the frequency of clones recognizing each peptide, normalized to the total frequency of HA-specific clones in all donors (D1, D2, D3, and D4), is plotted in the heatmap. The solid arrows highlight the peptides recognized by 3 subsets and the dashed arrows the peptides recognized by 3 donors.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1548560-f0006){#F6}

![HA-Specific cTfh and cNon-Tfh Clones Do Not Overlap, and HA-Specific cTfh CXCR3^+^ T Cell Clonotypes Can Be Detected in the tTfh CXCR3^+^ Subset\
(A) TCR CDR3α and CDR3β sequencing was performed on clones specific for the same HA H1/California peptide that had been generated from either the cTfh CXCR3^+^, cTfh CXCR3^−^, or cNon-Tfh subset in 3 donors. For each clone, the peptide specificity, the CDR3α and CDR3β amino acid (AA) sequences, and *TRAV/TRAJ* and *TRBV/TRBJ* gene usage are shown. Clones are grouped based on the peptide recognized.\
(B and C) The TCR CDR3α and CDR3β region sequences of 75 HA-specific clones generated from the blood populations were determined, and the *ex vivo* Vα and Vβ repertoires of tonsil and blood Tfh and non-Tfh populations from the same subject were searched for matching sequences. Matches were detected only in donor 2. The frequency distributions of each of the individual clonotypes detected in the tonsil tTfh CXCR3^+^ (B) and peripheral blood cTfh CXCR3^+^ (C) repertoires are shown, with yellow circles indicating the sequences that matched those of the HA-specific cTfh CXCR3^+^ clones generated from the peripheral blood of the same donor.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1548560-f0007){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                              SOURCE                                               IDENTIFIER
  ---------------------------------------------------------------- ---------------------------------------------------- -----------------------------------------
  Antibodies                                                                                                            
  Anti-human CD3 Brilliant Violet 605                              Becton Dickinson                                     Cat\#742623; RRID: AB_2740919
  Live/Dead Fixable Aqua                                           Invitrogen                                           Cat\#L34957
  Anti-human CD4 APC-Cy7                                           Becton Dickinson                                     Cat\#557871; RRID: AB_396913
  Anti-human CD45RA PE-TexasRed                                    Invitrogen                                           Cat\#MHCD45RA17; RRID: AB_1476948
  Anti-human CXCR3 PE-Cy5                                          Becton Dickinson                                     Cat\#551128; RRID: AB_394061
  Anti-human CXCR5 Alexa Fluor 488                                 Becton Dickinson                                     Cat\#558112; RRID: AB_397034
  Anti-human ICOS Brilliant Violet 711                             Becton Dickinson                                     Cat\#563833; RRID: AB_2738440
  Anti-human ICOS PE                                               BioLegend                                            Cat\#313508; RRID: AB_416332
  Anti-human PD-1 Brilliant Violet 421                             Becton Dickinson                                     Cat\#562516; RRID: AB_11153482
  Anti-human CD8 PE-Cy7                                            Becton Dickinson                                     Cat\#335822
  Anti-human CD14 FITC                                             Becton Dickinson                                     Cat\#555397; RRID: AB_395798
  Anti-human CD14 PE-Cy7                                           Becton Dickinson                                     Cat\#557742; RRID: AB_396848
  Anti-human CD16 PE-Cy7                                           Becton Dickinson                                     Cat\#557744; RRID: AB_396850
  Anti-human CD19 PE-Cy7                                           Becton Dickinson                                     Cat\#557835; RRID: AB_396893
  Anti-human CD25 PE-Cy7                                           Becton Dickinson                                     Cat\#335824
  Anti-human CD56 PE-Cy7                                           Becton Dickinson                                     Cat\#557747; RRID: AB_396853
  Anti-human IFN-gamma Alexa Fluor 700                             Becton Dickinson                                     Cat\#557995; RRID: AB_396977
  Anti-human IL-4 PE                                               Becton Dickinson                                     Cat\#554485; RRID: AB_395424
  Anti-human IL-21 Alexa Fluor 647                                 Becton Dickinson                                     Cat\#560493; RRID: AB_1645421
  Biological Samples                                                                                                    
  Peripheral blood of adults individual undergoing tonsillectomy   JR Hospital, Oxford, UK                              LABFLU002
  Tonsil samples of adults                                         JR Hospital, Oxford, UK                              LABFLU002
  Cone samples from peripheral blood of healthy individuals        UK National Blood Service                            N/A
  Chemicals, Peptides, and Recombinant Proteins                                                                         
  Haemagglutinin protein                                           Prof Stephen Harrison (Harvard Medical School, MA)   Influenza A Wisconsin/67/2005
  Overlapping peptides of Haemagglutinin protein                   GenScript                                            Influenza A California/04/2009
  Haemagglutinin protein                                           BEI Resources                                        Influenza A/California/04/2009
  Commercial Trivalent Influenza Vaccine                           Sanofi Pasteur                                       Split Virion, Inactivated
  Phytohemagglutinin purified                                      Remel                                                R30852801
  Critical Commercial Assays                                                                                            
  Human TCR Profiling Kit                                          MiLaboratory LLC                                     N/A
  NextSeq 500/550 High Output Kit v2.5 (300 Cycles)                Illumina                                             20024908
  RNeasy micro kit                                                 QIAGEN                                               74004
  Deposited Data                                                                                                        
  TCR sequencing data                                              Mendely Data                                         <https://doi.org/10.17632/wry2ddh8zx.1>
  Oligonucleotides                                                                                                      
  Primer MAC2 GGAACTTTCTGGGCTGGGGAAGAAGGTGTCTTCTGG                 [@R66]                                               N/A
  Primer MBC2 TGCTTCTGATGGCTCAAACACAGCGACCT                        [@R66]                                               N/A
  Primer M13 Forward: TTTTCCCAGTCACGAC                             Invitrogen                                           N/A
  Primer M13 Reverse: CAGGAAACAGCTATGAC                            Invitrogen                                           N/A
  Software and Algorithms                                                                                               
  MIGEC                                                            <https://milaboratory.com/software/>                 MiLaboratory LLC
  MiXCR                                                            <https://milaboratory.com/software/>                 MiLaboratory LLC
  VDJtools                                                         <https://milaboratory.com/software/>                 MiLaboratory LLC
  Cytoscape                                                        <https://cytoscape.org/>                             Cytoscape Version 3.6.1
  Open Gen5                                                        BioTek                                               N/A

###### Highlights

-   The blood and tonsil CD4^+^ T follicular helper (Tfh) repertoires overlap extensively

-   Dominant Tfh clonotypes differ from those of non-Tfh, which predominate in blood

-   Influenza-specific Tfh and non-Tfh clones exhibit repertoire differences

-   Influenza-specific Tfh clones in blood are found in the tonsil CXCR3^+^Tfh subset
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